← All companies
Organon & Co.
OGN - CIK 0001821825
Market cap$3.51 B
Rank#1689
SEC filings433
Organon & Co. trades as OGN and has a market capitalization of $3.51 B, making it the #1689 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $6.22B, down 2.9% from the prior year and net income of $187.00M. This page tracks Organon & Co. through 433 SEC filings, with financial statements and metrics updated as new reports are filed.
Key metrics
Revenue (latest FY)$6.22BFY 2025
Net income (latest FY)$187.00MFY 2025
Operating cash flow (latest FY)$700.00MFY 2025
Total assets (latest FY)$12.87BFY 2025
Gross margin53.3%latest FY
Net margin3.0%latest FY
Financial performance
Over the last 6 fiscal years Organon & Co.'s revenue declined from $7.78B to $6.22B, a compound annual decline rate of 3.7%. Net profit margin compressed from 41.4% to 3.0% over the same period - every figure below comes from the company's audited annual filings.
Key statistics
- Market cap
- $3.51 B
- Share price (derived)market cap / shares outstanding
- $13.38
- P/E ratio (trailing FY)
- 18.8
- EPS (diluted)FY 2025
- $0.72
- Shares outstandingas of 2026-04-27
- 0.26B
- Total equityas of 2026-03-31
- $903.00M
- Return on equity
- 20.7%
- Long-term debtas of 2026-03-31
- $8.57B
Latest filings
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-08 |
| Insider trade (amended) | 4/A | 2026-05-07 |
| Insider trade | 4 | 2026-05-07 |
| Quarterly report | 10-Q | 2026-05-04 |
| SCHEDULE 13G | - | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Proxy materials | DEFA14A | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
Recent press releases
- Organon Reports Results for the First Quarter Ended March 31, 2026
First quarter 2026 net income of $146 million and Adjusted EBITDA (non-GAAP) of $415 million, representing an Adjusted EBITDA margin of 28.4%.
- Organon Reports Results for the Fourth Quarter and Full Year ...
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025 · Full year 2025 revenue of $6.2 billion, down 3% on both an ...
- Organon Reports Results for the Second Quarter Ended June 30 ...
Net income for the second quarter of 2025 was $145 million, or $0.56 per diluted share, compared with $195 million, or $0.75 per diluted share, ...
Similar companies
The largest companies sharing Organon & Co.'s SEC industry classification (pharmaceutical preparations).
Frequently asked questions
What is Organon & Co.'s market cap?
Organon & Co. (OGN) has a market capitalization of $3.51 B as of 2026-06-10, ranking #1689 among US-listed companies.
How much revenue does Organon & Co. make?
Organon & Co. reported revenue of $6.22B for fiscal year 2025, a decrease of 2.9% year over year.
Is Organon & Co. profitable?
Yes. Organon & Co. reported net income of $187.00M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.